Clinical versus laboratory screening for sexually transmitted infections prior to insertion of intrauterine contraception among women living with HIV/AIDS: A randomized controlled trial

Human Reproduction

Volumn 30, Issue 7, 2015, Pages 1573-1579

  Kakaire, Othman ^a   Byamugisha, Josaphat Kayogoza ^a   Tumwesigye, Nazarius Mbona ^b   Gemzell Danielsson, Kristina ^c  

^a MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^b MAKERERE UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Uganda)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

acquired immunodeficiency syndrome; intrauterine contraceptive device; IUC removal; laboratory screening; sexually transmitted infections

Indexed keywords

ABDOMINAL PAIN; ADULT; ARTICLE; BLEEDING; CD4 LYMPHOCYTE COUNT; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DEVICE REMOVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; INTRAUTERINE CONTRACEPTIVE DEVICE; INTRAUTERINE DEVICE EXPULSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MORBIDITY; OUTCOME ASSESSMENT; PELVIC EXAMINATION; PELVIC INFLAMMATORY DISEASE; RANDOMIZED CONTROLLED TRIAL; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE; VAGINA DISCHARGE; ADVERSE EFFECTS; HIV INFECTIONS; SEXUALLY TRANSMITTED DISEASES; SINGLE BLIND PROCEDURE; STATISTICS AND NUMERICAL DATA; UGANDA; YOUNG ADULT;

ADULT; DEVICE REMOVAL; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INTRAUTERINE DEVICES; PELVIC INFLAMMATORY DISEASE; SEXUALLY TRANSMITTED DISEASES; SINGLE-BLIND METHOD; UGANDA; YOUNG ADULT;

EID: 84936752300     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dev109     Document Type: Article

References (32)

1. Asavapiriyanont S, Lolekha R, Roongpisuthipong A, Wiratchai A, Kaoiean S, Suksripanich O, Chalermchockcharoenkit A, Ausavapipit J, Srifeungfung S, Pattanasin S et al. Sexually transmitted infections among HIV-infected women in Thailand. BMC Public Health 2013;13:373.
2. Buhling KJ, Zite NB, Lotke P, Black K. Worldwide use of intrauterine contraception: a review. Contraception 2014;89:162-173.
3. Centre for Disease Control and Prevention. U. S. Selected Practice Recommendations for Contraceptive Use, 2013: adapted from the World Health Organization Selected Practice Recommendations for Contraceptive Use, 2nd Edition. http://www. cdc. gov/mmwr/preview/ mmwrhtml/rr6205a1. htm (24 November 2014, date last accessed).
4. Clifton D, Kaneda T, Ashford L. Family PlanningWorldwide, 2008 Data Sheet. Washington, DC, USA: Population Reference Bureau.
5. Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992; 339:785-788.
6. French R, Sorhaindo AM, Van Vliet HAAM, Mansour DD, Robinson AA, Logan S, Helmerhorst FM, Guillebaud J, Cowan FM. Progestogenreleasing intrauterine systems versus other forms of reversible contraceptives for contraception. Cochrane Database Syst Rev 2004; doi:10. 1002/14651858. CD001776. pub2.
7. Grimes DA. Intrauterine device and upper-genital-tract infection. Lancet 2000;356:1013-1019.
8. Grimes DA, Lopez LM, Schulz KF. Antibiotic prophylaxis for intrauterine contraceptive device insertion. Cochrane Database Syst Rev 1999. doi:10. 1002/14651858. CD001327.
9. Hadgu A, Westrom L, Brooks CA, Reynolds GH, Thompson SE. Predicting acute pelvic inflammatory disease: a multivariate analysis. Am J Obstet Gynecol 1998;155:954-960.
10. Heikinheimo O, Lehtovirta P, Suni J, Paavonen J. The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women-effects on bleeding patterns, ovarian function and genital shedding of HIV. Hum Reprod 2006;21:2857-2861.
11. Jacobson L, Westrom L. Objectivized diagnosis of acute pelvic inflammatory disease. Diagnostic and prognostic value of routine laparoscopy. Am J Obstet Gynecol 1969;105:1088-1098.
12. Kulier R, O'Brien P, HelmerhorstFM, Usher-Patel M, d'Arcangues C. Copper containing, framed intrauterine devices for contraception. Cochrane Database Syst Rev 2007. doi:10. 1002/14651858. CD005347. pub3.
13. Luukkainen T, Allonen H, Haukkamaa M, Holma P, Pyorala T, Terho J, Toivonen J, Batar I, Lampe L, Andersson K et al. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study. Contraception 1987;36:169-179.
14. MansourD, InkiP, Gemzell-DanielssonK. Efficacyof contraceptivemethods:A review of the literature. Eur J Contracept Reprod Health Care 2010;15:4-16.
15. MohllajeeAP, CurtisKM, FlanaganRG, RinehartW, GaffieldML, PetersonHB. Keeping up with evidence a new system forWHO's evidence-based family planning guidance. Am J Prev Med 2005;28:483-490.
16. Mohllajee AP, Curtis KM, Peterson HB. Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection A systematic review. Contraception 2006;73:145-153.
17. Morrison CS, Sekadde-Kigondu C, Sinei SK, Weiner DH, Kwok C, Kokonya D. Is the intrauterine device appropriate contraception for HIV-1-infected women. BJOG 2001;108:784-790.
18. Peipert JF, Zhao Q, Allsworth JE, Petrosky E, Madden T, Eisenberg D, Secura G. Continuation and satisfaction of reversible contraception. Obstet Gynecol 2011;117:1105-1113.
19. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Br Med J 2010; 340:c332.
20. Shaamash AH, Sayed GH, Hussien MM, Shaaban MM. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development. Contraception 2005; 72:346-351.
21. Shelton JD. Risk of clinical pelvic inflammatory disease attributable to an intrauterine device. Lancet 2001;357:443.
22. Sinei SK, Schulz KF, Lamptey PR, Grimes DA, Mati JK, Rosenthal SM, Rosenberg MJ, Riara G, Njage PN, Bhullar VB. Preventing IUCD-related pelvic infection: the efficacy of prophylactic doxycycline at insertion. Br J Obstet Gynaecol 1990;97:412-419.
23. Sinei SK, Morrison CS, Sekadde-Kigondu C, Allen M, Kokonya D. Complications of use of intrauterine devices among HIV-1-infected women. Lancet 1998;351:1238-1241.
24. Steen R, Shapiro K. Intrauterine contraceptive devices and risk of pelvic inflammatory disease: standard of care in high STI prevalence settings. Reprod Health Matters 2004;12:136-143.
25. Trussell J. Contraceptive failure in the United States. Contraception 2004; 70:89-96.
26. Trussell J, Lalla AM, DoanQV, Reyes E, Pinto L, Gricar J. Cost effectiveness of contraceptives in the United States. Contraception 2009;79:5-14.
27. Tseng A, Hills-Nieminen C. Drug interactions between antiretrovirals and hormonal contraceptives. Expert Opin Drug Metab Toxicol 2013; 9:559-572.
28. Uganda Bureau of Statistics (UBOS) and ICF International Inc. 2012. Uganda Demographic and Health Survey 2011. Kampala, Uganda: UBOS and Claverton, Maryland: ICF International Inc. http://www. ubos. org/ onlinefiles/uploads/ubos/UDHS/UDHS2011. pdf (24 November 2014, date last accessed).
29. United Nations, 2013. Trends in Contraceptive Methods UsedWorldwide http://www. un. org/en/development/desa/population/publications/ pdf/popfacts/PopFacts-2013-9-new. pdf (24 November 2014, date last accessed).
30. Venkatesh KK, van der Straten A, Mayer KH, Blanchard K, Ramjee G, Lurie MN, Chipato T, Padian NS, de Bruyn G. African women recently infected with HIV-1 and HSV-2 have increased risk of acquiring Neisseria gonorrhoeae and Chlamydia trachomatis in the Methods for Improving Reproductive Health in Africa trial. Sex Transm Dis 2011;38:562-570.
31. Walsh T, Grimes D, Frezieres R, Nelson A, Bernstein L, Coulson A, Bernstein G. Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices. IUD Study Group. Lancet 1998; 351:1005-1008.
32. World Health Organisation. Medical Eligibility Criteria for Contraceptive Use, 4th edn. Geneva: World Health Organization, 2009. http://whqlibdoc. who. int/publications/2010/9789241563888-eng. pdf (24 November 2014, date last accessed).